These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6489166)

  • 1. Should pulmonary exacerbations in cystic fibrosis be treated with antibiotics?
    Bosso JA
    Drug Intell Clin Pharm; 1984 Oct; 18(10):825-6. PubMed ID: 6489166
    [No Abstract]   [Full Text] [Related]  

  • 2. The management of cystic fibrosis. Observations on gentamycin when used with other antibiotics in pulmonary infections associated with cystic fibrosis.
    Shwachman H; Khaw KT; Kowalski SM
    Clin Pediatr (Phila); 1975 Dec; 14(12):1115-8. PubMed ID: 1192683
    [No Abstract]   [Full Text] [Related]  

  • 3. Exacerbations in cystic fibrosis: 3--Management.
    Smyth A; Elborn JS
    Thorax; 2008 Feb; 63(2):180-4. PubMed ID: 18234661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

  • 5. Cystic fibrosis, intravenous antibiotics, and home therapy.
    Hammond LJ; Caldwell S; Campbell PW
    J Pediatr Health Care; 1991; 5(1):24-30. PubMed ID: 1990112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients.
    Denton M; Wilcox MH
    J Antimicrob Chemother; 1997 Oct; 40(4):468-74. PubMed ID: 9372414
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of action of antibiotics in chronic pulmonary pseudomonas infection.
    Høiby N; Giwercman B; Jensen ET; Pedersen SS; Koch C; Kharazmi A
    Adv Pharmacol; 1994; 30():53-84. PubMed ID: 7833297
    [No Abstract]   [Full Text] [Related]  

  • 8. Maintenance of Pseudomonas antibiotic sensitivity in patients with cystic fibrosis treated with inhaled antibiotics.
    Wittenberg DF
    S Afr Med J; 1987 Mar; 71(5):335-6. PubMed ID: 3563765
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-Pseudomonas aeruginosa (Pa) antibiotic therapy and cystic fibrosis].
    Bellon G; Gilly R
    Rev Mal Respir; 1991; 8(2):263. PubMed ID: 1907014
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhaled tobramycin (TOBI).
    Bonsignore CL
    Pediatr Nurs; 1998; 24(3):258-9. PubMed ID: 9987427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.
    Mukhopadhyay S; Singh M; Ogston S; Ryan G; Smyth R
    J R Soc Med; 1998; 91 Suppl 34(Suppl 34):25-9. PubMed ID: 9709385
    [No Abstract]   [Full Text] [Related]  

  • 13. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.
    Parry MF; Neu HC
    J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.
    Paporisz U; Posselt HG; Wönne R; Ristow W; Röser D; Knothe H; Bender SW
    Monogr Paediatr; 1979; 10():31-3. PubMed ID: 460275
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic therapy for chronic infection of pseudomonas in the lung.
    Høiby N
    Annu Rev Med; 1993; 44():1-10. PubMed ID: 8476233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
    Michel BC
    Chest; 1988 Aug; 94(2 Suppl):129S-140S. PubMed ID: 3293939
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-pseudomonas activity of azlocillin during pulmonary infection in patients with cystic fibrosis.
    Levy J; Baran D; Klastersky J
    J Antimicrob Chemother; 1982 Sep; 10(3):235-8. PubMed ID: 6815156
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia.
    Geddes DM
    Chest; 1988 Aug; 94(2 Suppl):140S-145S. PubMed ID: 3293940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use and abuse of antibiotics, including in management of pulmonary manifestations in cystic fibrosis.
    Kulczycki LL; Wientzen R
    Monogr Paediatr; 1979; 10():27-30. PubMed ID: 460274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.